Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yaping Huang

5PUBLICATIONS
8CO-AUTHORS
AllergyAnimal welfarePharmaceutical delivery technologiesNanotoxicology, health and safetyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Mar 23, 2026
Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) database.

Maohua Chen, Chengjie Ke, Yaping Huang

|Feb 26, 2026
Safety assessment of frunevetmab for osteoarthritis pain in cats: disproportionality analysis of the Food and Drug Administration Animal Drug Adverse Events database.

Xiaoheng Lai, Li Lin, Yan Chen

|Jul 27, 2025
Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.

Yaping Huang, Chengjie Ke, Maohua Chen

|Sep 21, 2024
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.

Chengjie Ke, Maohua Chen, Li Lin

|Jun 15, 2024
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer.

Yaping Huang, Chengjie Ke, Jiaqin Cai

Pageof 1

Frequent Collaborators

4 joint publications

Maohua Chen

3 joint publications

Chengjie Ke

2 joint publications

Li Lin

1 joint publications

Xiaoheng Lai

1 joint publications

Yan Chen

1 joint publications

Jiaqin Cai

1 joint publications

Xiaoxia Wei

1 joint publications

Hong Sun

Frequent Collaborators

4 joint publications

Maohua Chen

3 joint publications

Chengjie Ke

2 joint publications

Li Lin

1 joint publications

Xiaoheng Lai

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.8K
Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
09:05

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents

Published on : Jan 10, 2014

8.0K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.0K
See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

8.8K
Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents
09:05

Meal Duration as a Measure of Orofacial Nociceptive Responses in Rodents

Published on : Jan 10, 2014

8.0K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.0K
See more related videos